Pub Date : 2025-11-27DOI: 10.1016/j.jnha.2025.100740
Jung-Hwan Kim , Yu-Jin Kwon , Yaeji Lee , Taehwa Han , Mi Young Lim , Seok-Jae Heo , Ji-Won Lee
Objectives
The role of beverage consumption in dementia prevention, particularly regarding substitution effects and interactions with modifiable risk factors, remains unclear. This study aimed to evaluate the associations of major beverage types and their substitution effects with the risk of all-cause dementia.
Design
A prospective cohort study.
Setting and participants
We included 118,963 dementia-free participants (2006–2010 baseline) with complete dietary questionnaires from the UK Biobank.
Measurements
Self-reported intake of sugar-sweetened beverages, artificially sweetened beverages, natural juices, coffee, and tea was assessed through 24-h dietary recall. The primary outcome was incident all-cause dementia, ascertained through linked primary care, hospital admission, and mortality registration data. Associations between beverage intake and dementia risk were evaluated using Cox proportional hazards models, yielding hazard ratios (HRs) and 95% confidence intervals (CIs). Substitution modeling assessed the effects of replacing one beverage with another. Interaction analyses explored variations by modifiable risk factors, including obesity, hypertension, depression, or dyslipidemia.
Results
Over 13.45 years, 992 all-cause dementia cases were recorded. Higher sugar-sweetened beverage intake (>1 glass/day) was associated with an increased risk of all-cause dementia (HR, 1.61; 95% CI, 1.28–2.02; P < 0.001). Coffee and tea consumption were associated with a lower risk of all-cause dementia. Substituting sugar-sweetened beverages or artificially sweetened beverages with coffee or tea significantly reduced the risk of all-cause dementia. These protective associations were strongest among individuals with obesity, hypertension, depression, or dyslipidemia.
Conclusion
Replacing sugar-sweetened beverages or artificially sweetened beverages with coffee or tea was associated with a reduced risk of dementia, particularly among individuals with modifiable risk factors. These findings support beverage substitution as a simple, targeted strategy for mitigating the risk of dementia.
饮料消费在痴呆症预防中的作用,特别是在替代效应和与可改变的风险因素的相互作用方面,仍不清楚。本研究旨在评估主要饮料类型及其替代效应与全因痴呆风险的关系。设计前瞻性队列研究。环境和参与者我们纳入了118,963名无痴呆的参与者(2006-2010年基线),并从英国生物库中收集了完整的饮食问卷。测量方法:通过24小时的饮食召回来评估含糖饮料、人工加糖饮料、天然果汁、咖啡和茶的自我报告摄入量。主要结局为偶发性全因痴呆,通过相关的初级保健、住院和死亡率登记数据确定。使用Cox比例风险模型评估饮料摄入量与痴呆风险之间的关系,得出风险比(hr)和95%置信区间(ci)。替代模型评估了用一种饮料代替另一种饮料的效果。相互作用分析探讨了可改变的危险因素的变化,包括肥胖、高血压、抑郁或血脂异常。结果在13.45岁期间,共记录992例全因痴呆病例。较高的含糖饮料摄入量(每天1杯)与全因痴呆风险增加相关(HR, 1.61; 95% CI, 1.28-2.02; P < 0.001)。喝咖啡和茶可以降低患全因痴呆的风险。用咖啡或茶代替含糖饮料或人工加糖饮料可以显著降低患全因痴呆的风险。这些保护性关联在肥胖、高血压、抑郁或血脂异常的个体中最强。结论:用咖啡或茶代替含糖饮料或人工加糖饮料与降低痴呆风险有关,特别是在具有可改变风险因素的个体中。这些发现支持饮料替代作为一种简单的、有针对性的策略来减轻痴呆症的风险。
{"title":"Associations of Individual Beverage Types and Substitution with Dementia Risk: A UK Biobank Cohort Study","authors":"Jung-Hwan Kim , Yu-Jin Kwon , Yaeji Lee , Taehwa Han , Mi Young Lim , Seok-Jae Heo , Ji-Won Lee","doi":"10.1016/j.jnha.2025.100740","DOIUrl":"10.1016/j.jnha.2025.100740","url":null,"abstract":"<div><h3>Objectives</h3><div>The role of beverage consumption in dementia prevention, particularly regarding substitution effects and interactions with modifiable risk factors, remains unclear. This study aimed to evaluate the associations of major beverage types and their substitution effects with the risk of all-cause dementia.</div></div><div><h3>Design</h3><div>A prospective cohort study.</div></div><div><h3>Setting and participants</h3><div>We included 118,963 dementia-free participants (2006–2010 baseline) with complete dietary questionnaires from the UK Biobank.</div></div><div><h3>Measurements</h3><div>Self-reported intake of sugar-sweetened beverages, artificially sweetened beverages, natural juices, coffee, and tea was assessed through 24-h dietary recall. The primary outcome was incident all-cause dementia, ascertained through linked primary care, hospital admission, and mortality registration data. Associations between beverage intake and dementia risk were evaluated using Cox proportional hazards models, yielding hazard ratios (HRs) and 95% confidence intervals (CIs). Substitution modeling assessed the effects of replacing one beverage with another. Interaction analyses explored variations by modifiable risk factors, including obesity, hypertension, depression, or dyslipidemia.</div></div><div><h3>Results</h3><div>Over 13.45 years, 992 all-cause dementia cases were recorded. Higher sugar-sweetened beverage intake (>1 glass/day) was associated with an increased risk of all-cause dementia (HR, 1.61; 95% CI, 1.28–2.02; <em>P</em> < 0.001). Coffee and tea consumption were associated with a lower risk of all-cause dementia. Substituting sugar-sweetened beverages or artificially sweetened beverages with coffee or tea significantly reduced the risk of all-cause dementia. These protective associations were strongest among individuals with obesity, hypertension, depression, or dyslipidemia.</div></div><div><h3>Conclusion</h3><div>Replacing sugar-sweetened beverages or artificially sweetened beverages with coffee or tea was associated with a reduced risk of dementia, particularly among individuals with modifiable risk factors. These findings support beverage substitution as a simple, targeted strategy for mitigating the risk of dementia.</div></div>","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100740"},"PeriodicalIF":4.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To evaluate the prevalence of the Determinants of Malnutrition in Aged Persons (DoMAP) and identify determinants of malnutrition among older adults attending primary healthcare.
Design and setting
Prospective, observational, monocentric study in primary healthcare.
Participants
500 older adults.
Measurements
Malnutrition was diagnosed using the Global Leadership Initiative on Malnutrition (GLIM) criteria. Potential causes of malnutrition were assessed by the attending physician using the DoMAP model with a 1:1 recruitment of malnourished and non-malnourished older persons.
Results
Malnourished individuals (mean age 81.7 ± 5.0 years; 59% women) exhibited a significantly higher prevalence of almost all DoMAP determinants compared to non-malnourished persons, particularly low intake (88 vs. 11%), high requirements (83 vs. 49%), poor appetite (73 vs. 9%), shopping difficulties (59 vs. 26%), inflammation (81 vs. 49%), gastrointestinal disease (17 vs. 2%), cancer (11 vs. 1%), depression (35 vs. 19%), dementia (21 vs. 6%), polypharmacy (60 vs. 38%), and hospitalization (27 vs. 4%). The mean total determinants count was significantly higher in malnourished participants (14.9 ± 5.0) than in non-malnourished ones (6.8 ± 4.4; p < 0.001). Regression analysis revealed low intake as the strongest determinant at Level1; poor appetite, forgetting to eat, shopping difficulties and inflammation at Level2; gastrointestinal disease, cancer and depression at Level3, and frailty and hospitalization at Level4.
Conclusion
This study highlights the complex multifactorial nature of malnutrition in older adults attending primary healthcare, confirming the superior role of low intake and poor appetite among other determinants. The DoMAP model offers a structured framework for potential causative factors of malnutrition in older subjects.
{"title":"Potential causes of malnutrition in older adults in primary healthcare—A cross-sectional study","authors":"Stefan Pfannkuch , Rainer Wirth , Ulrike Trampisch , Dorothee Volkert , Maryam Pourhassan","doi":"10.1016/j.jnha.2025.100745","DOIUrl":"10.1016/j.jnha.2025.100745","url":null,"abstract":"<div><h3>Objectives</h3><div>To evaluate the prevalence of the Determinants of Malnutrition in Aged Persons (DoMAP) and identify determinants of malnutrition among older adults attending primary healthcare.</div></div><div><h3>Design and setting</h3><div>Prospective, observational, monocentric study in primary healthcare.</div></div><div><h3>Participants</h3><div>500 older adults.</div></div><div><h3>Measurements</h3><div>Malnutrition was diagnosed using the Global Leadership Initiative on Malnutrition (GLIM) criteria. Potential causes of malnutrition were assessed by the attending physician using the DoMAP model with a 1:1 recruitment of malnourished and non-malnourished older persons.</div></div><div><h3>Results</h3><div>Malnourished individuals (mean age 81.7 ± 5.0 years; 59% women) exhibited a significantly higher prevalence of almost all DoMAP determinants compared to non-malnourished persons, particularly low intake (88 vs. 11%), high requirements (83 vs. 49%), poor appetite (73 vs. 9%), shopping difficulties (59 vs. 26%), inflammation (81 vs. 49%), gastrointestinal disease (17 vs. 2%), cancer (11 vs. 1%), depression (35 vs. 19%), dementia (21 vs. 6%), polypharmacy (60 vs. 38%), and hospitalization (27 vs. 4%). The mean total determinants count was significantly higher in malnourished participants (14.9 ± 5.0) than in non-malnourished ones (6.8 ± 4.4; <em>p</em> < 0.001). Regression analysis revealed low intake as the strongest determinant at Level1; poor appetite, forgetting to eat, shopping difficulties and inflammation at Level2; gastrointestinal disease, cancer and depression at Level3, and frailty and hospitalization at Level4.</div></div><div><h3>Conclusion</h3><div>This study highlights the complex multifactorial nature of malnutrition in older adults attending primary healthcare, confirming the superior role of low intake and poor appetite among other determinants. The DoMAP model offers a structured framework for potential causative factors of malnutrition in older subjects.</div></div>","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100745"},"PeriodicalIF":4.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.jnha.2025.100739
Won Man Lee , So Im Ryu , Myoung-Nam Lim , Ji Won Han , Jong Bin Bae , Tae Hui Kim , Kyung Phil Kwak , Bong Jo Kim , Shin Gyeom Kim , Jeong Lan Kim , Seok Woo Moon , Joon Hyuk Park , Seung-Ho Ryu , Dong Woo Lee , Seok Bum Lee , Jung Jae Lee , Dong Young Lee , Ki Woong Kim , Jin Hyeong Jhoo
Objectives
South Korea has a relatively high baseline omega-3 fatty acids (O3FA) status due to dietary patterns. However, evidence on additional benefits of O3FA supplementation remains limited. This study examined the 8-year longitudinal effects of O3FA supplement use on cognitive performance among community-dwelling older adults in South Korea.
Design
Prospective longitudinal cohort study.
Setting and participants: Data were from the Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD). A total of 4,949 adults aged ≥60 years (mean age = 69.55 ± 6.56; 44.2% men) were included, and 2,053 completed the 8-year follow-up (2010–2012 to 2018–2020).
Measurements
O3FA supplement use was assessed through structured questionnaires on regular intake of omega-3 or fish oil supplements. Cognitive performance was assessed using the Korean version of Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet Neuropsychological Assessment Battery (CERAD-K[N]), and total and memory domain scores were analyzed. Longitudinal changes were examined using repeated measures analysis of covariance and linear mixed-effects models (LMMs; unweighted and weighted), adjusting for potential covariates.
Results
Over the 8 years, CERAD-K[N] (t = −2.686, p = .007) and memory domain (t = −4.026, p < .001) scores significantly improved among O3FA users. In the weighted LMM, significant time × supplement duration interactions were observed (CERAD-K[N]: β = 2.398, 95% CI 1.207–3.589, p < .001; memory: β = 1.050, 95% CI 0.643–1.456, p < .001), indicating greater improvement in long-term users.
Conclusion
O3FA supplement use was associated with better maintenance of cognitive function over eight years. These findings suggest a potential role of O3FA supplementation in supporting cognitive health during aging.
韩国由于饮食模式的原因,其omega-3脂肪酸(O3FA)的基线水平相对较高。然而,关于补充O3FA的额外益处的证据仍然有限。本研究考察了韩国社区老年人服用O3FA补充剂对认知表现的8年纵向影响。前瞻性纵向队列研究。环境和参与者:数据来自韩国认知衰老和痴呆纵向研究(KLOSCAD)。共纳入4949名年龄≥60岁的成年人(平均年龄69.55±6.56岁,男性44.2%),2053人完成了为期8年的随访(2010-2012至2018-2020)。通过定期摄入omega-3或鱼油补充剂的结构化问卷来评估so3fa补充剂的使用情况。认知表现采用韩国版《阿尔茨海默病评估包神经心理评估系统》(CERAD-K[N])进行评估,并分析总得分和记忆域得分。纵向变化采用重复测量分析的协方差和线性混合效应模型(lmm;未加权和加权)进行检验,调整潜在协变量。结果8年间,O3FA患者的CERAD-K[N]评分(t = - 2.686, p = .007)和记忆域评分(t = - 4.026, p < .001)均有显著改善。在加权LMM中,观察到显著的时间与补充时间的相互作用(CERAD-K[N]: β = 2.398, 95% CI 1.107 - 3.589, p < .001;记忆:β = 1.050, 95% CI 0.643-1.456, p < .001),表明长期使用者有更大的改善。结论服用o3fa补充剂可更好地维持8年以上的认知功能。这些发现表明补充O3FA在支持衰老过程中的认知健康方面具有潜在作用。
{"title":"Association Between Omega-3 Supplement Use and Cognitive Function in Korean Older Adults: An 8-Year Longitudinal Cohort Study","authors":"Won Man Lee , So Im Ryu , Myoung-Nam Lim , Ji Won Han , Jong Bin Bae , Tae Hui Kim , Kyung Phil Kwak , Bong Jo Kim , Shin Gyeom Kim , Jeong Lan Kim , Seok Woo Moon , Joon Hyuk Park , Seung-Ho Ryu , Dong Woo Lee , Seok Bum Lee , Jung Jae Lee , Dong Young Lee , Ki Woong Kim , Jin Hyeong Jhoo","doi":"10.1016/j.jnha.2025.100739","DOIUrl":"10.1016/j.jnha.2025.100739","url":null,"abstract":"<div><h3>Objectives</h3><div>South Korea has a relatively high baseline omega-3 fatty acids (O3FA) status due to dietary patterns. However, evidence on additional benefits of O3FA supplementation remains limited. This study examined the 8-year longitudinal effects of O3FA supplement use on cognitive performance among community-dwelling older adults in South Korea.</div></div><div><h3>Design</h3><div>Prospective longitudinal cohort study.</div><div>Setting and participants: Data were from the Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD). A total of 4,949 adults aged ≥60 years (mean age = 69.55 ± 6.56; 44.2% men) were included, and 2,053 completed the 8-year follow-up (2010–2012 to 2018–2020).</div></div><div><h3>Measurements</h3><div>O3FA supplement use was assessed through structured questionnaires on regular intake of omega-3 or fish oil supplements. Cognitive performance was assessed using the Korean version of Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet Neuropsychological Assessment Battery (CERAD-K[N]), and total and memory domain scores were analyzed. Longitudinal changes were examined using repeated measures analysis of covariance and linear mixed-effects models (LMMs; unweighted and weighted), adjusting for potential covariates.</div></div><div><h3>Results</h3><div>Over the 8 years, CERAD-K[N] (t = −2.686, p = .007) and memory domain (t = −4.026, p < .001) scores significantly improved among O3FA users. In the weighted LMM, significant time × supplement duration interactions were observed (CERAD-K[N]: β = 2.398, 95% CI 1.207–3.589, p < .001; memory: β = 1.050, 95% CI 0.643–1.456, p < .001), indicating greater improvement in long-term users.</div></div><div><h3>Conclusion</h3><div>O3FA supplement use was associated with better maintenance of cognitive function over eight years. These findings suggest a potential role of O3FA supplementation in supporting cognitive health during aging.</div></div>","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100739"},"PeriodicalIF":4.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.jnha.2025.100744
Qihang Yang , Yibo Qiao , Pengfei Shi , Zongqiang Huang
Background
Osteosarcopenic obesity (OSO), the coexistence of osteoporosis, sarcopenia, and obesity, has been linked to poor health outcomes, but its longitudinal impact on aging-related trajectories remains unclear.
Methods
We used data from the English Longitudinal Study of Ageing (ELSA), including adults aged ≥50 years with up to 14 years of follow-up. Physical frailty, cognitive function, and mental health were assessed every 2 years. OSO components were defined at baseline, and participants were categorized by the number of conditions (OSO/0–3). Linear mixed-effects models estimated the associations of OSO and its components with outcome trajectories, adjusting for covariates. Sensitivity analyses were conducted.
Results
Participants with osteoporosis, sarcopenia, or obesity showed worse progression of frailty and cognition than those without. Mental health exhibited minimal and inconsistent change over time. Increasing OSO burden (from 0 to 3 conditions) was associated with progressively greater frailty and cognitive decline. Sarcopenia was consistently linked to all three outcomes, whereas osteoporosis was primarily associated with frailty progression and obesity with subtle changes in cognition. Sensitivity analyses were largely consistent with the primary analysis.
Conclusions
OSO and its components are important predictors of adverse aging-related trajectories.
{"title":"Osteosarcopenic obesity and the progression of physical frailty, cognition function, and mental health: First longitudinal evidence from ELSA","authors":"Qihang Yang , Yibo Qiao , Pengfei Shi , Zongqiang Huang","doi":"10.1016/j.jnha.2025.100744","DOIUrl":"10.1016/j.jnha.2025.100744","url":null,"abstract":"<div><h3>Background</h3><div>Osteosarcopenic obesity (OSO), the coexistence of osteoporosis, sarcopenia, and obesity, has been linked to poor health outcomes, but its longitudinal impact on aging-related trajectories remains unclear.</div></div><div><h3>Methods</h3><div>We used data from the English Longitudinal Study of Ageing (ELSA), including adults aged ≥50 years with up to 14 years of follow-up. Physical frailty, cognitive function, and mental health were assessed every 2 years. OSO components were defined at baseline, and participants were categorized by the number of conditions (OSO/0–3). Linear mixed-effects models estimated the associations of OSO and its components with outcome trajectories, adjusting for covariates. Sensitivity analyses were conducted.</div></div><div><h3>Results</h3><div>Participants with osteoporosis, sarcopenia, or obesity showed worse progression of frailty and cognition than those without. Mental health exhibited minimal and inconsistent change over time. Increasing OSO burden (from 0 to 3 conditions) was associated with progressively greater frailty and cognitive decline. Sarcopenia was consistently linked to all three outcomes, whereas osteoporosis was primarily associated with frailty progression and obesity with subtle changes in cognition. Sensitivity analyses were largely consistent with the primary analysis.</div></div><div><h3>Conclusions</h3><div>OSO and its components are important predictors of adverse aging-related trajectories.</div></div>","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100744"},"PeriodicalIF":4.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-25DOI: 10.1016/j.jnha.2025.100732
Qiao Liu , Miaomiao Wang , Qiaoling Yang , Hui Liu , Lu Han , Ni Sang , Li Cheng
Objectives
To compare the diagnostic accuracy of seven sarcopenia screening tools against four international guidelines.
Methods
This cross-sectional study recruited 330 Chinese older patients from a tertiary hospital. Sarcopenia was diagnosed based on muscle mass, strength, and physical performance using four guidelines: the Asian Working Group for Sarcopenia (AWGS) 2019 consensus, The updated version of the European Working Group on Sarcopenia in Older People (EWGSOP2), Foundation for the National Institutes of Health Sarcopenia Project (FNIH), and the International Working Group on Sarcopenia (IWGS). Seven screening tools included: SARC-F, MSRA-7, MSRA-5, Calf Circumference (CC), Finger-ring Test, SARC-CalF, and Ishii Score. Diagnostic accuracy was assessed using sensitivity, specificity, and receiver operating characteristic (ROC) curve analysis, including area under the curve (AUC).
Results
This study enrolled 330 older adults with type 2 diabetes, including 172 women and 158 men, with a mean age of 68.35 ± 6.32 years. Sarcopenia prevalence ranged from 7.58% to 27.27%. The Ishii Score showed the highest accuracy for screening sarcopenia in older patients with T2DM. Under the 2019 consensus of the Asian Working Group for Sarcopenia criteria, sensitivity ranged from 13.33% (SARC-F) to 80.00% (Ishii Score), and specificity ranged from 27.92% (MSRA-7) to 91.67% (SARC-F). AUCs ranged from 0.51 (MSRA-5) to 0.79 (Ishii Score). In subgroup analyses, the Ishii Score also demonstrated the highest AUC values in men (0.79) and in women (0.83). The performance of tools varied against other three golden standards, with sensitivity (8.00%–98.04%), specificity (27.21%–91.67%), and AUC (0.51–0.88).
Conclusions
The Ishii score demonstrated the highest overall diagnostic accuracy for sarcopenia screening. CC may be ideal for rapid screening, while SARC-F suits confirmatory testing. Further validation of these tools in diverse settings is needed.
{"title":"Comparison of Seven Sarcopenia Screening Tools in Older Type 2 Diabetes Patients Using Four Diagnostic Criteria","authors":"Qiao Liu , Miaomiao Wang , Qiaoling Yang , Hui Liu , Lu Han , Ni Sang , Li Cheng","doi":"10.1016/j.jnha.2025.100732","DOIUrl":"10.1016/j.jnha.2025.100732","url":null,"abstract":"<div><h3>Objectives</h3><div>To compare the diagnostic accuracy of seven sarcopenia screening tools against four international guidelines.</div></div><div><h3>Methods</h3><div>This cross-sectional study recruited 330 Chinese older patients from a tertiary hospital. Sarcopenia was diagnosed based on muscle mass, strength, and physical performance using four guidelines: the Asian Working Group for Sarcopenia (AWGS) 2019 consensus, The updated version of the European Working Group on Sarcopenia in Older People (EWGSOP2), Foundation for the National Institutes of Health Sarcopenia Project (FNIH), and the International Working Group on Sarcopenia (IWGS). Seven screening tools included: SARC-F, MSRA-7, MSRA-5, Calf Circumference (CC), Finger-ring Test, SARC-CalF, and Ishii Score. Diagnostic accuracy was assessed using sensitivity, specificity, and receiver operating characteristic (ROC) curve analysis, including area under the curve (AUC).</div></div><div><h3>Results</h3><div>This study enrolled 330 older adults with type 2 diabetes, including 172 women and 158 men, with a mean age of 68.35 ± 6.32 years. Sarcopenia prevalence ranged from 7.58% to 27.27%. The Ishii Score showed the highest accuracy for screening sarcopenia in older patients with T2DM. Under the 2019 consensus of the Asian Working Group for Sarcopenia criteria, sensitivity ranged from 13.33% (SARC-F) to 80.00% (Ishii Score), and specificity ranged from 27.92% (MSRA-7) to 91.67% (SARC-F). AUCs ranged from 0.51 (MSRA-5) to 0.79 (Ishii Score). In subgroup analyses, the Ishii Score also demonstrated the highest AUC values in men (0.79) and in women (0.83). The performance of tools varied against other three golden standards, with sensitivity (8.00%–98.04%), specificity (27.21%–91.67%), and AUC (0.51–0.88).</div></div><div><h3>Conclusions</h3><div>The Ishii score demonstrated the highest overall diagnostic accuracy for sarcopenia screening. CC may be ideal for rapid screening, while SARC-F suits confirmatory testing. Further validation of these tools in diverse settings is needed.</div></div>","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100732"},"PeriodicalIF":4.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-22DOI: 10.1016/j.jnha.2025.100729
Ryo Sato , Yohei Sawaya , Tamaki Hirose , Takahiro Shiba , Lu Yin , Shuntaro Tsuji , Tomohiko Urano
{"title":"Anthropometrically estimated calf muscle circumference is a marker for early detection of muscle mass decline in older adults: Second report","authors":"Ryo Sato , Yohei Sawaya , Tamaki Hirose , Takahiro Shiba , Lu Yin , Shuntaro Tsuji , Tomohiko Urano","doi":"10.1016/j.jnha.2025.100729","DOIUrl":"10.1016/j.jnha.2025.100729","url":null,"abstract":"","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100729"},"PeriodicalIF":4.0,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145571661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-21DOI: 10.1016/j.jnha.2025.100733
Bingxuan Weng , Jin Jin , Lixue Huang , Yu Wang , Wenshu Jiao , Jingnan Li , Meng Ma , Mengyuan Wang , Xunliang Tong , Yanming Li
Objective
Frailty is increasingly recognized in older adults with lower respiratory tract infections (LRTIs), yet the optimal assessment tool and its prognostic value remain unclear. This study evaluates the prevalence, inter-tool agreement, and predictive performance of four frailty measures in this population.
Methods
Older adults hospitalized with LRTIs were prospectively enrolled. Frailty was assessed using the Clinical Frailty Scale (CFS), Fried Frailty Phenotype (FFP), FRAIL Scale (FS), and Short Physical Performance Battery (SPPB). The primary outcome was 1-year mortality; secondary outcomes included in-hospital mortality and decline in activities of daily living (ADL) at discharge and 1 year. Inter-tool agreement was assessed using Cohen’s kappa, and predictive performance was evaluated by the area under the receiver operating characteristic curve (AUROC).
Results
Of 361 patients (median age 74 years; 61.5% male), frailty prevalence ranged from 18.0% (CFS) to 57.3% (SPPB), with fair to moderate inter-tool agreement. In-hospital and 1-year mortality were 1.4% and 11.5%, respectively. ADL decline occurred in 18.3% at discharge and 21.6% at 1 year. All tools were associated with 1-year mortality, but only the FFP and SPPB were associated with ADL decline.
The FFP demonstrated the the most consistent discriminative performance, with relatively high AUC and a good trade-off between sensitivity and specificity. The CFS exhibited high specificity (0.823–0.881), whereas the SPPB demonstrated high sensitivity (0.724–1.000) across different outcomes. None of the tools adequately predicted 1-year ADL decline (AUC < 0.600).
Conclusions
Frailty is prevalent and prognostic in older adults with LRTIs. The FFP provided consistent prediction of mortality and short-term ADL decline, the CFS was effective for confirming high-risk patients, and the SPPB was useful for early risk screening. The limited prediction of long-term functional decline highlights the need for LRTIs-specific frailty assessment instruments.
{"title":"Comparing various frailty instruments for predicting adverse outcomes in older patients hospitalized with lower respiratory tract infections","authors":"Bingxuan Weng , Jin Jin , Lixue Huang , Yu Wang , Wenshu Jiao , Jingnan Li , Meng Ma , Mengyuan Wang , Xunliang Tong , Yanming Li","doi":"10.1016/j.jnha.2025.100733","DOIUrl":"10.1016/j.jnha.2025.100733","url":null,"abstract":"<div><h3>Objective</h3><div>Frailty is increasingly recognized in older adults with lower respiratory tract infections (LRTIs), yet the optimal assessment tool and its prognostic value remain unclear. This study evaluates the prevalence, inter-tool agreement, and predictive performance of four frailty measures in this population.</div></div><div><h3>Methods</h3><div>Older adults hospitalized with LRTIs were prospectively enrolled. Frailty was assessed using the Clinical Frailty Scale (CFS), Fried Frailty Phenotype (FFP), FRAIL Scale (FS), and Short Physical Performance Battery (SPPB). The primary outcome was 1-year mortality; secondary outcomes included in-hospital mortality and decline in activities of daily living (ADL) at discharge and 1 year. Inter-tool agreement was assessed using Cohen’s kappa, and predictive performance was evaluated by the area under the receiver operating characteristic curve (AUROC).</div></div><div><h3>Results</h3><div>Of 361 patients (median age 74 years; 61.5% male), frailty prevalence ranged from 18.0% (CFS) to 57.3% (SPPB), with fair to moderate inter-tool agreement. In-hospital and 1-year mortality were 1.4% and 11.5%, respectively. ADL decline occurred in 18.3% at discharge and 21.6% at 1 year. All tools were associated with 1-year mortality, but only the FFP and SPPB were associated with ADL decline.</div><div>The FFP demonstrated the the most consistent discriminative performance, with relatively high AUC and a good trade-off between sensitivity and specificity. The CFS exhibited high specificity (0.823–0.881), whereas the SPPB demonstrated high sensitivity (0.724–1.000) across different outcomes. None of the tools adequately predicted 1-year ADL decline (AUC < 0.600).</div></div><div><h3>Conclusions</h3><div>Frailty is prevalent and prognostic in older adults with LRTIs. The FFP provided consistent prediction of mortality and short-term ADL decline, the CFS was effective for confirming high-risk patients, and the SPPB was useful for early risk screening. The limited prediction of long-term functional decline highlights the need for LRTIs-specific frailty assessment instruments.</div></div>","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100733"},"PeriodicalIF":4.0,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145571659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-21DOI: 10.1016/j.jnha.2025.100731
Huilong Xie , Xuebing Sun , Liyu Huang , Tao Wang , Qi Yu , Min Hu , Jingwen Liao
Introduction
Moderate-vigorous physical activity (MVPA) is known to reduce the risk of cardiovascular disease (CVD), but its role in mitigating or exacerbating this risk under exposure to air pollution remains unclear. This study investigates the associations between MVPA and CVD in the context of air pollution among both sexes.
Methods
This nationwide, cross-sectional study included 17,138 middle-aged and elderly people from the 2018 wave of the China Health and Retirement Longitudinal Study. Physical activity was assessed using the International Physical Activity Questionnaire. Data on air pollutants, including particulate matter, sulfur dioxide, ozone, nitrogen dioxide, carbon monoxide, and air quality index, were obtained from the China High Air Pollutants dataset and the Science Data Bank. CVD was identified based on self-reported physician diagnoses of heart disease or stroke.
Results
More physically active participants were associated with lower CVD prevalence, while all air pollutants were linked to higher prevalence in the top exposure quartile. Physically inactive individuals exhibited the highest CVD prevalence across different levels of air pollution. Under high levels of air pollution, MVPA generally exhibited an inverse association with CVD prevalence in males (P for overall < 0.05), but not in females (P for overall > 0.05). In addition, MVPA duration positively mediated the associations between air pollutant exposure and CVD prevalence, with mediation proportions ranging from 10.10 to 33.30% in females and 5.14 to 7.53% in males.
Conclusions
This study highlights that, under high levels of air pollution, the inverse association between MVPA and CVD prevalence was generally observed among males. Moreover, MVPA mediates the relationships between all air pollutants and CVD prevalence.
{"title":"Sex-specific associations between physical activity and cardiovascular disease under air pollution among the middle-aged and elderly population: A nationwide cross-sectional study in China","authors":"Huilong Xie , Xuebing Sun , Liyu Huang , Tao Wang , Qi Yu , Min Hu , Jingwen Liao","doi":"10.1016/j.jnha.2025.100731","DOIUrl":"10.1016/j.jnha.2025.100731","url":null,"abstract":"<div><h3>Introduction</h3><div>Moderate-vigorous physical activity (MVPA) is known to reduce the risk of cardiovascular disease (CVD), but its role in mitigating or exacerbating this risk under exposure to air pollution remains unclear. This study investigates the associations between MVPA and CVD in the context of air pollution among both sexes.</div></div><div><h3>Methods</h3><div>This nationwide, cross-sectional study included 17,138 middle-aged and elderly people from the 2018 wave of the China Health and Retirement Longitudinal Study. Physical activity was assessed using the International Physical Activity Questionnaire. Data on air pollutants, including particulate matter, sulfur dioxide, ozone, nitrogen dioxide, carbon monoxide, and air quality index, were obtained from the China High Air Pollutants dataset and the Science Data Bank. CVD was identified based on self-reported physician diagnoses of heart disease or stroke.</div></div><div><h3>Results</h3><div>More physically active participants were associated with lower CVD prevalence, while all air pollutants were linked to higher prevalence in the top exposure quartile. Physically inactive individuals exhibited the highest CVD prevalence across different levels of air pollution. Under high levels of air pollution, MVPA generally exhibited an inverse association with CVD prevalence in males (P for overall < 0.05), but not in females (P for overall > 0.05). In addition, MVPA duration positively mediated the associations between air pollutant exposure and CVD prevalence, with mediation proportions ranging from 10.10 to 33.30% in females and 5.14 to 7.53% in males.</div></div><div><h3>Conclusions</h3><div>This study highlights that, under high levels of air pollution, the inverse association between MVPA and CVD prevalence was generally observed among males. Moreover, MVPA mediates the relationships between all air pollutants and CVD prevalence.</div></div>","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100731"},"PeriodicalIF":4.0,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145571658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-20DOI: 10.1016/j.jnha.2025.100730
Jaya Singh Kshatri , Kavitha AK , Haimanti Bhattacharya , Sanghamitra Pati
{"title":"Anaemia, Iron Deficiency, and Functional Outcomes in Rural Older Indians: Insights from the Odisha Tribal Family Health Survey","authors":"Jaya Singh Kshatri , Kavitha AK , Haimanti Bhattacharya , Sanghamitra Pati","doi":"10.1016/j.jnha.2025.100730","DOIUrl":"10.1016/j.jnha.2025.100730","url":null,"abstract":"","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100730"},"PeriodicalIF":4.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145571652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-18DOI: 10.1016/j.jnha.2025.100727
Cheng Huang , Yuan Yu , Weihao Liang , Jiayong Li , Yilong Wang , Fangfei Wei , Tianyu Xu , Yu Ning , Zhe Zhen , Jia Liu , Wengen Zhu , Yugang Dong , Chen Liu , Peisen Huang
Background
The association between high protein intake and cardiovascular diseases (CVD) was conflicting and the role of age in this relationship was rarely studied. This study aimed to examine the association of high protein diet with the risk of CVD and the interaction of age in this association.
Methods
Participants from UK biobank (2007–2023) with at least 1 dietary questionnaire and without history of chronic diseases at baseline were included. High-protein diet was defined as protein intake ≥1.8 g·kg−1·day−1. The primary outcome was major adverse cardiovascular events (MACE). Cox regression analyses and restricted cubic spline (RCS) regression analyses were performed.
Results
Among 19420 participants, the median (IQR) age was 54 (14) years and 14137 (72.8%) were women. With a follow-up of 256258.9 person-years, 967 MACEs occurred. After adjusting for sociodemographic and cardiovascular risk factors, participants with high-protein intake had higher risk of MACE compared with participants with low-protein intake (HR = 1.21, 95% CI, 1.02–1.44, P = 0.027). High-protein diet was also associated with higher risk of all-cause mortality, heart failure, myocardial infarction and CVD death (HR = 1.39, 95% CI, 1.17–1.65, P < 0.001; HR = 1.43, 95% CI, 1.07–1.92, P = 0.015; HR = 1.50, 95% CI, 1.07–2.10, P = 0.019; HR = 1.73, 95% CI, 1.12–2.65, P = 0.013, respectively). Among participants aged over 55 years, high protein intake was associated with higher risk of MACE (HR = 1.36, 95% CI, 1.13-1.63, P = 0.001). Whereas, among participants younger than 55 years, the association was not significant (HR = 0.75, 95% CI, 0.51–1.11, P = 0.099, Pinteraction = 0.003). Similar interaction between age and high protein diet was witnessed in the association of high protein intake and stroke (Pinteraction = 0.019).
Conclusions
Higher protein intake was related to higher incidence of MACE in participants over 55 years old, but the association was not evident in their counterparts younger than 55 years old.
背景:高蛋白摄入与心血管疾病(CVD)之间的关系是相互矛盾的,年龄在这种关系中的作用很少被研究。本研究旨在探讨高蛋白饮食与心血管疾病风险的关系以及年龄在这种关系中的相互作用。方法:受试者来自英国生物银行(2007-2023),至少有1份饮食问卷,基线时无慢性疾病史。高蛋白饮食定义为蛋白质摄入量≥1.8 g·kg-1·day-1。主要终点为主要不良心血管事件(MACE)。采用Cox回归分析和限制性三次样条(RCS)回归分析。结果:在19420名参与者中,中位(IQR)年龄为54(14)岁,14137(72.8%)为女性。随访256258.9人年,发生967例mace。在调整了社会人口统计学和心血管危险因素后,高蛋白摄入的参与者与低蛋白摄入的参与者相比,MACE的风险更高(HR = 1.21, 95% CI, 1.02-1.44, P = 0.027)。高蛋白饮食还与全因死亡率、心力衰竭、心肌梗死和心血管疾病死亡的高风险相关(HR = 1.39, 95% CI, 1.17-1.65, P < 0.001; HR = 1.43, 95% CI, 1.07-1.92, P = 0.015; HR = 1.50, 95% CI, 1.07-2.10, P = 0.019; HR = 1.73, 95% CI, 1.12-2.65, P = 0.013)。在55岁以上的参与者中,高蛋白摄入与MACE的高风险相关(HR = 1.36, 95% CI, 1.13-1.63, P = 0.001)。然而,在年龄小于55岁的参与者中,相关性不显著(HR = 0.75, 95% CI, 0.51-1.11, P = 0.099, P - interaction = 0.003)。高蛋白饮食与脑卒中的关系中,年龄与高蛋白饮食之间也存在类似的相互作用(p - interaction = 0.019)。结论:在55岁以上的参与者中,较高的蛋白质摄入量与较高的MACE发生率相关,但在55岁以下的参与者中,这种关联并不明显。
{"title":"Associations between High Protein Intake and Cardiovascular Diseases by Age Groups: A Cohort Study","authors":"Cheng Huang , Yuan Yu , Weihao Liang , Jiayong Li , Yilong Wang , Fangfei Wei , Tianyu Xu , Yu Ning , Zhe Zhen , Jia Liu , Wengen Zhu , Yugang Dong , Chen Liu , Peisen Huang","doi":"10.1016/j.jnha.2025.100727","DOIUrl":"10.1016/j.jnha.2025.100727","url":null,"abstract":"<div><h3>Background</h3><div>The association between high protein intake and cardiovascular diseases (CVD) was conflicting and the role of age in this relationship was rarely studied. This study aimed to examine the association of high protein diet with the risk of CVD and the interaction of age in this association.</div></div><div><h3>Methods</h3><div>Participants from UK biobank (2007–2023) with at least 1 dietary questionnaire and without history of chronic diseases at baseline were included. High-protein diet was defined as protein intake ≥1.8 g·kg<sup>−1</sup>·day<sup>−1</sup>. The primary outcome was major adverse cardiovascular events (MACE). Cox regression analyses and restricted cubic spline (RCS) regression analyses were performed.</div></div><div><h3>Results</h3><div>Among 19420 participants, the median (IQR) age was 54 (14) years and 14137 (72.8%) were women. With a follow-up of 256258.9 person-years, 967 MACEs occurred. After adjusting for sociodemographic and cardiovascular risk factors, participants with high-protein intake had higher risk of MACE compared with participants with low-protein intake (HR = 1.21, 95% CI, 1.02–1.44, <em>P</em> = 0.027). High-protein diet was also associated with higher risk of all-cause mortality, heart failure, myocardial infarction and CVD death (HR = 1.39, 95% CI, 1.17–1.65, <em>P</em> < 0.001; HR = 1.43, 95% CI, 1.07–1.92, <em>P</em> = 0.015; HR = 1.50, 95% CI, 1.07–2.10, <em>P</em> = 0.019; HR = 1.73, 95% CI, 1.12–2.65, <em>P</em> = 0.013, respectively). Among participants aged over 55 years, high protein intake was associated with higher risk of MACE (HR = 1.36, 95% CI, 1.13-1.63, <em>P</em> = 0.001). Whereas, among participants younger than 55 years, the association was not significant (HR = 0.75, 95% CI, 0.51–1.11, <em>P</em> = 0.099, <em>P<sub>interaction</sub></em> = 0.003). Similar interaction between age and high protein diet was witnessed in the association of high protein intake and stroke (<em>P<sub>interaction</sub></em> = 0.019).</div></div><div><h3>Conclusions</h3><div>Higher protein intake was related to higher incidence of MACE in participants over 55 years old, but the association was not evident in their counterparts younger than 55 years old.</div></div>","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"30 1","pages":"Article 100727"},"PeriodicalIF":4.0,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145558459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}